{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:52:59Z","timestamp":1791859979234,"version":"4.3.4"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01699","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T04:48:57Z","timestamp":1597121337000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["IL-27 Regulated CD4+IL-10+ T Cells in Experimental Sj\u00f6gren Syndrome"],"prefix":"10.3389","volume":"11","author":[{"given":"Jingjing","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev-med-043015-123313","article-title":"Mechanisms and new strategies for primary Sjogren's syndrome","volume":"68","author":"Mavragani","year":"2017","journal-title":"Annu Rev Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-pathol-012513-104728","article-title":"Sjogren's syndrome","volume":"9","author":"Mavragani","year":"2014","journal-title":"Annu Rev Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1601-0825.2009.01582.x","article-title":"Cytokines in Sjogren's syndrome","volume":"15","author":"Roescher","year":"2009","journal-title":"Oral Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.immuni.2016.02.011","article-title":"Interleukin-27-producing CD4+ T cells regulate protective immunity during malaria parasite infection","volume":"44","author":"Kimura","year":"2016","journal-title":"Immunity."},{"key":"B5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","article-title":"The immunobiology of interleukin-27","volume":"33","author":"Yoshida","year":"2015","journal-title":"Annu Rev Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ni1375","article-title":"Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells","volume":"7","author":"Batten","year":"2006","journal-title":"Nat Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.4049\/jimmunol.172.4.2225","article-title":"WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27","volume":"172","author":"Pflanz","year":"2004","journal-title":"J Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7684","DOI":"10.4049\/jimmunol.174.12.7684","article-title":"Positive and negative regulation of the IL-27 receptor during lymphoid cell activation","volume":"174","author":"Villarino","year":"2005","journal-title":"J Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.4049\/jimmunol.173.9.5626","article-title":"The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity","volume":"173","author":"Artis","year":"2004","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.4049\/jimmunol.170.10.4886","article-title":"Cutting edge: role of IL-27\/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment","volume":"170","author":"Takeda","year":"2003","journal-title":"J Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1089\/10799900360708632","article-title":"IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells","volume":"23","author":"Hibbert","year":"2003","journal-title":"J Interferon Cytokine Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S1074-7613(01)00206-0","article-title":"WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection","volume":"15","author":"Yoshida","year":"2001","journal-title":"Immunity."},{"key":"B14","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/all.13691","article-title":"IL-27 signaling deficiency develops Th17-enhanced Th2-dominant inflammation in murine allergic conjunctivitis model","volume":"74","author":"Chen","year":"2019","journal-title":"Allergy."},{"key":"B15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/infdis\/jix581","article-title":"IL-27\/IL-27 receptor signaling provides protection in Clostridium difficile-induced colitis","volume":"217","author":"Wang","year":"2018","journal-title":"J Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/ni1540","article-title":"Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells","volume":"8","author":"Fitzgerald","year":"2007","journal-title":"Nat Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"10190","DOI":"10.1073\/pnas.1703100114","article-title":"Treg-specific IL-27Ralpha deletion uncovers a key role for IL-27 in Treg function to control autoimmunity","volume":"114","author":"Do","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.immuni.2012.06.014","article-title":"The cytokines interleukin 27 and interferon-gamma promote distinct Treg cell populations required to limit infection-induced pathology","volume":"37","author":"Hall","year":"2012","journal-title":"Immunity."},{"key":"B19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4049\/jimmunol.176.1.237","article-title":"IL-27 limits IL-2 production during Th1 differentiation","volume":"176","author":"Villarino","year":"2006","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.3389\/fimmu.2017.01392","article-title":"Induction of peripheral tolerance in ongoing autoimmune inflammation requires interleukin 27 signaling in dendritic cells","volume":"8","author":"Thome","year":"2017","journal-title":"Front Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/ni1537","article-title":"Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10","volume":"8","author":"Stumhofer","year":"2007","journal-title":"Nat Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4049\/immunohorizons.1800083","article-title":"IL-27 and TCR stimulation promote T cell expression of multiple inhibitory receptors","volume":"3","author":"DeLong","year":"2019","journal-title":"Immunohorizons."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/ni1541","article-title":"A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells","volume":"8","author":"Awasthi","year":"2007","journal-title":"Nat Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4049\/jimmunol.0901233","article-title":"Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells","volume":"183","author":"Pot","year":"2009","journal-title":"J Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.4049\/jimmunol.0900568","article-title":"IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells","volume":"183","author":"Murugaiyan","year":"2009","journal-title":"J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.4049\/jimmunol.172.10.5986","article-title":"IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells","volume":"172","author":"Vieira","year":"2004","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fimmu.2019.00320","article-title":"Reversal of new onset type 1 diabetes by oral salmonella-based combination therapy and mediated by regulatory T-cells in NOD mice","volume":"10","author":"Mbongue","year":"2019","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/j.gastro.2019.09.002","article-title":"Suppressive and gut reparative functions of human type 1 T-regulatory cells","volume":"157","author":"Cook","year":"2019","journal-title":"Gastroenterology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"10443","DOI":"10.1073\/pnas.1705599114","article-title":"Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development","volume":"114","author":"Yu","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12967-017-1133-8","article-title":"Generation of donor-specific Tr1 cells to be used after kidney transplantation and definition of the timing of their in vivo infusion in the presence of immunosuppression","volume":"15","author":"Mfarrej","year":"2017","journal-title":"J Transl Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2337\/db09-1168","article-title":"Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant","volume":"59","author":"Gagliani","year":"2010","journal-title":"Diabetes."},{"key":"B32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","article-title":"The immunobiology of the interleukin-12 family: room for discovery","volume":"50","author":"Tait Wojno","year":"2019","journal-title":"Immunity."},{"key":"B33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000493398","article-title":"Intranasal administration of IL-27 ameliorates nasal allergic responses and symptoms","volume":"178","author":"Suzuki","year":"2019","journal-title":"Int Arch Allergy Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1189\/jlb.3A1215-540R","article-title":"Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells","volume":"100","author":"Zhu","year":"2016","journal-title":"J Leukocyte Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1038\/emm.2013.89","article-title":"In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis","volume":"45","author":"Moon","year":"2013","journal-title":"Exp Mol Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1136\/ard.2007.083360","article-title":"Interleukin 27 attenuates collagen-induced arthritis","volume":"67","author":"Niedbala","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41598-020-57507-8","article-title":"Enhanced STAT3 phosphorylation and PD-L1 expression in myeloid dendritic cells indicate impaired IL-27Ralpha signaling in type 1 diabetes","volume":"10","author":"Parackova","year":"2020","journal-title":"Sci Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1016\/j.celrep.2019.11.010","article-title":"Interleukin-27 is essential for type 1 diabetes development and Sjogren syndrome-like inflammation","volume":"29","author":"Ciecko","year":"2019","journal-title":"Cell Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3109\/03009742.2011.620574","article-title":"Elevated levels of interleukin-27 in patients with Sjogren's syndrome","volume":"41","author":"Xia","year":"2012","journal-title":"Scand J Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3109\/03009742.2014.962080","article-title":"Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis","volume":"44","author":"Xia","year":"2015","journal-title":"Scand J Rheumatol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1136\/ard.2007.077537","article-title":"Amelioration of human lupus-like phenotypes in MRL\/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1)","volume":"67","author":"Sugiyama","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.4049\/jimmunol.179.5.3268","article-title":"Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis","volume":"179","author":"Fitzgerald","year":"2007","journal-title":"J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"R172","DOI":"10.1186\/ar3925","article-title":"Gene therapy using IL-27 ameliorates Sjogren's syndrome-like autoimmune exocrinopathy","volume":"14","author":"Lee","year":"2012","journal-title":"Arthritis Res Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.7150\/thno.37351","article-title":"Mesenchymal stem cell transplantation alleviates experimental Sjogren's syndrome through IFN-beta\/IL-27 signaling axis","volume":"9","author":"Yao","year":"2019","journal-title":"Theranostics."},{"key":"B45","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu Rev Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.4049\/jimmunol.166.9.5530","article-title":"IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells","volume":"166","author":"Levings","year":"2001","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00005-017-0482-6","article-title":"Role of TGF-beta in self-peptide regulation of autoimmunity","volume":"66","author":"Singh","year":"2018","journal-title":"Arch Immunol Ther Exp."},{"key":"B48","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41575-020-0273-0","article-title":"JAK-STAT pathway targeting for the treatment of inflammatory bowel disease","volume":"17","author":"Salas","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jaut.2012.07.009","article-title":"Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation","volume":"40","author":"Jin","year":"2013","journal-title":"J Autoimmun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1002\/eji.201242977","article-title":"Type I interferon potentiates T-cell receptor mediated induction of IL-10-producing CD4+ T cells","volume":"43","author":"Corre","year":"2013","journal-title":"Eur J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.4049\/jimmunol.1601045","article-title":"IL-10 receptor signaling is essential for TR1 cell function in vivo","volume":"198","author":"Brockmann","year":"2017","journal-title":"J Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01699\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T04:49:00Z","timestamp":1597121340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01699\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,11]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2020.01699"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01699","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,11]]},"article-number":"1699"}}